Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 3,000 shares at $5.20 ($16K) on 2017-05-12, disclosed to the SEC on 2017-05-15.
Open-market purchase of $16k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 1,100 | $6K | 36.8% |
| 2 | $5.17 | 1,900 | $10K | 63.2% |
| Total | $5.18 avg | 3,000 | $16K | 100% |
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |